Cited by 357Advanced Drug Delivery SystemsBarrier Structure and Function StudiesNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 217 of the 219 references it cites were found in a registry or an index.

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Open access

Bourganis, Vassilis, Kammona, Olga, Alexopoulos, Aleck, Kiparissides, Costas·2018·European Journal of Pharmaceutics and Biopharmaceutics

DOI 10.1016/j.ejpb.2018.05.009

Open this paper in CoChat — free account Open PDF

Abstract

Central nervous system (CNS) disorders (e.g., multiple sclerosis, Alzheimer's disease, etc.) represent a growing public health issue, primarily due to the increased life expectancy and the aging population. The treatment of such disorders is notably elaborate and requires the delivery of therapeutics to the brain in appropriate amounts to elicit a pharmacological response. However, despite the major advances both in neuroscience and drug delivery research, the administration of drugs to the CNS still remains elusive. It is commonly accepted that effectiveness-related issues arise due to the inability of parenterally administered macromolecules to cross the Blood-Brain Barrier (BBB) in order to access the CNS, thus impeding their successful delivery to brain tissues. As a result, the direct Nose-to-Brain delivery has emerged as a powerful strategy to circumvent the BBB and deliver drugs to the brain. The present review article attempts to highlight the different experimental and computational approaches pursued so far to attain and enhance the direct delivery of therapeutic agents to the brain and shed some light on the underlying mechanisms involved in the pathogenesis and treatment of neurological disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ejpb.2018.05.009

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 3,037
Macromolecular Crowding and Confinement: Biochemical, Biophysical, and Potential Physiological Consequences
Zhou, H., Rivas, G., & Minton, A. P. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125817 · Cited by 2,160
Nanoemulsions versus microemulsions: terminology, differences, and similarities
McClements, D. J. (2011) · Soft Matter · doi:10.1039/c2sm06903b · Cited by 1,786
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,494
Barrier properties of mucus
Cone, R. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.
Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,293
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
Abuchowski, A., McCoy, J. R., Palczuk, N. C., Es, T. V., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,276
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,256
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Intranasal delivery of biologics to the central nervous system
Lochhead, J. J., & Thorne, R. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.002 · Cited by 1,214
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review
Dash, T. K., & Konkimalla, V. B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.064 · Cited by 1,023
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
Almeida, A. J., & Souto, E. B. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 817
The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
Engelhardt, B., & Sorokin, L. M. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0177-0 · Cited by 792
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 771
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues
Peppas, N. A., & Buri, P. A. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90050-1 · Cited by 721
Chitosan nanoparticle as protein delivery carrier—Systematic examination of fabrication conditions for efficient loading and release
Gan, Q., & Wang, T. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.04.009 · Cited by 712
Characteristics of Compounds that Cross the Blood-Brain Barrier
Banks, W. A. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-s1-s3 · Cited by 710
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 700
Axonal transport: cargo-specific mechanisms of motility and regulation
Maday, S., Twelvetrees, A. E., Moughamian, A. J., & Holzbaur, E. L. F. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.019 · Cited by 683
Protein misfolding in neurodegenerative diseases: Implications and strategies
Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., McCampbell, A., Leblanc, G., Venkateswaran, A., Nurmi, A., et al. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0077-5 · Cited by 675
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Coarse-Graining Methods for Computational Biology
Saunders, M. G., & Voth, G. A. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130348 · Cited by 576
Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species
Johnston, M., Zakharov, A., Papaiconomou, C., Salmasi, G., & Armstrong, D. (2004) · Cerebrospinal Fluid Research · doi:10.1186/1743-8454-1-2 · Cited by 572
Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review
Djupesland, P. G. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0108-9 · Cited by 563
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
Ugwoke, M. I., Agu, R. U., Verbeke, N., & Kinget, R. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.009 · Cited by 559
The Nose Revisited: A Brief Review of the Comparative Structure, Function, and Toxicologic Pathology of the Nasal Epithelium
Harkema, J. R., Carey, S. A., & Wagner, J. G. (2006) · Toxicologic Pathology · doi:10.1080/01926230600713475 · Cited by 513
Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective
Jones, H., Chen, Y., Gibson, C., Heimbach, T., Parrott, N., Peters, S., Snoeys, J., Upreti, V., Zheng, M., & Hall, S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.37 · Cited by 488
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487
Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482 · cited 5×
“While the transcellular pathway is mainly relevant for the rigorous transport of more lipophilic entities, the absorption of more hydrophilic drugs is carried out by a slow, passive diffusion-driven process through aqueous, fluid-filled channels and exhibits an inverse relation to the molecular weight of the drug [25].”
BackgroundInfluential
Is nose-to-brain transport of drugs in man a reality?
Illum, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022539 · Cited by 439
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 432
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery
Chen, M., Sonaje, K., Chen, K., & Sung, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.087 · Cited by 427
Crowding and hydrodynamic interactions likely dominate in vivo macromolecular motion
Ando, T., & Skolnick, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011354107 · Cited by 416
Penetration and enzymatic barriers to peptide and protein absorption
Lee, V. H. L., & Yamamoto, A. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90018-5 · Cited by 412
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 405
Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting
Fazil, M., Md, S., Haque, S., Kumar, M., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.04.013 · Cited by 379
Nanoparticles and the Brain: Cause for Concern?
Oberdörster, G., Elder, A. C. P., & Rinderknecht, A. L. (2009) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2009.gr02 · Cited by 377
Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies
Seju, U., Kumar, A., & Sawant, K. K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.07.025 · Cited by 367
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres — A review
Versypt, A. N. F., Pack, D. W., & Braatz, R. D. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.015 · Cited by 355
Quantitative analysis of the olfactory pathway for drug delivery to the brain
Thorne, R. G., Emory, C. R., Ala, T. A., & Frey, W. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00637-6 · Cited by 352
Current approaches to enhance CNS delivery of drugs across the brain barriers
Lu, C.-T., Zhao, Y.-Z., Wong, H. L., Cai, J., Peng, L., & Tian, X.-Q. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s61288 · Cited by 350
Quantitative analysis of drug delivery to the brain via nasal route
Kozlovskaya, L., Abou-Kaoud, M., & Stepensky, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.053 · Cited by 345
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
Fricker, G., Kromp, T., Wendel, A., Blume, A., Zirkel, J., Rebmann, H., Setzer, C., Quinkert, R., Martin, F. J., & Müller-Goymann, C. C. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0130-x · Cited by 338
Drug transport in brain via the cerebrospinal fluid.
Pardridge, W. M. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-7 · Cited by 316
The Nasal Approach to Delivering Treatment for Brain Diseases: An Anatomic, Physiologic, and Delivery Technology Overview
Djupesland, P. G., Messina, J. C., & Mahmoud, R. A. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.41 · Cited by 309
Absorption Enhancers: Applications and Advances
Aungst, B. J. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9307-4 · Cited by 309
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting
Wang, X., Chi, N., & Tang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.005 · Cited by 307
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model
Md, S., Khan, R. A., Mustafa, G., Chuttani, K., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.007 · Cited by 307
Designing Nanoparticle Translocation through Membranes by Computer Simulations
Ding, H., Tian, W., & Ma, Y. (2012) · ACS Nano · doi:10.1021/nn2038862 · Cited by 290
Nanoparticles for nasal vaccination
Csaba, N., García-Fuentes, M., & Alonso, M. J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.005 · Cited by 285
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
Gizurarson, S. S. (2012) · Current Drug Delivery · doi:10.2174/156720112803529828 · Cited by 273
Mechanics of airflow in the human nasal airways
Doorly, D., Taylor, D. J., & Schroter, R. C. (2008) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2008.07.027 · Cited by 272
Absorption Enhancers for Nasal Drug Delivery
Davis, S. S., & Illum, L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00003 · Cited by 264
Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration
Lochhead, J. J., Wolak, D. J., Pizzo, M. E., & Thorne, R. G. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.215 · Cited by 262
Progress in gene therapy for neurological disorders
Simonato, M., Bennett, J., Boulis, N. M., Castro, M. G., Fink, D. J., Goins, W. F., Gray, S. J., Lowenstein, P. R., Vandenberghe, L. H., Wilson, T. J., et al. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.56 · Cited by 257
Drug Metabolism in the Nasal Mucosa
Sarkar, M. A. (1992) · Pharmaceutical Research · doi:10.1023/a:1018911206646 · Cited by 253
Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration
Yang, Z.-Z., Zhang, Y.-Q., Wang, Z.-Z., Wu, K., Lou, J.-N., & Qi, X.-R. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.009 · Cited by 248
On developing coarse-grained models for biomolecular simulation: a review
Riniker, S., Allison, J. R., & van Gunsteren, W. F. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp40934h · Cited by 247
Numerical simulations for detailed airflow dynamics in a human nasal cavity
Wen, J., Inthavong, K., Tu, J. Y., & Wang, S. (2008) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2008.01.012 · Cited by 243
Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis
Ross, T. M., Martinez, P. M., Renner, J. C., Thorne, R. G., Hanson, L. R., & Frey, W. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.011 · Cited by 242
Nasal Delivery of High Molecular Weight Drugs
Özsoy, Y., Güngör, S., & Cevher, E. (2009) · Molecules · doi:10.3390/molecules14093754 · Cited by 242
Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles
Kanazawa, T., Akiyama, F., Kakizaki, S., Takashima, Y., & Seta, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.036 · Cited by 242
Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease
Muntimadugu, E., Dhommati, R., Jain, A., Challa, V. G. S., Mahira, S., & Khan, W. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.012 · Cited by 242
Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration
Wen, Z., Yan, Z., Hu, K., Pang, Z., Cheng, X., Guo, L., Zhang, Q., Jiang, X., Fang, L., & Lai, R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.022 · Cited by 241
Trigeminal collaterals in the nasal epithelium and olfactory bulb: A potential route for direct modulation of olfactory information by trigeminal stimuli
Schaefer, M. L., Böttger, B., Silver, W. L., & Finger, T. E. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10143 · Cited by 239
Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy
Rassu, G., Soddu, E., Posadino, A. M., Pintus, G., Sarmento, B., Giunchedi, P., & Gavini, E. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.01.031 · Cited by 239
In silico models of aerosol delivery to the respiratory tract — Development and applications
Longest, P. W., & Holbrook, L. T. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.009 · Cited by 236
Thiolated chitosans
Bernkop‐Schnürch, A., Hornof, M., & Guggi, D. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00147-4 · Cited by 235
Physicochemical Properties of Nanoparticles Regulate Translocation across Pulmonary Surfactant Monolayer and Formation of Lipoprotein Corona
Hu, G., Jiao, B., Shi, X., Valle, R. P., Fan, Q., & Zuo, Y. Y. (2013) · ACS Nano · doi:10.1021/nn4054683 · Cited by 228
Pegylation: engineering improved pharmaceuticals for enhanced therapy
Molineux, G. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)80004-4 · Cited by 226
Role of the physiochemical properties of mucus in the protection of the respiratory epithelium
Fullana, S. G., Zahm, J., Plotkowski, M. C., Beck, G., & Puchelle, É. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05040477 · Cited by 220
Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study
Alam, S., Mustafa, G., Khan, Z. I., Islam, F., Bhatnagar, A., Ahmad, F. J., & Kumar (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35329 · Cited by 219
Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration
Liu, Z., Jiang, M., Kang, T., Miao, D., Gu, G., Song, Q., Yao, L., Hu, Q., Tu, Y., Pang, Z., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.003 · Cited by 219
Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression
Haque, S., Md, S., Sahni, J. K., Ali, J., & Baboota, S. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.10.011 · Cited by 219
Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting
Mahajan, H. S., Mahajan, M. S., Nerkar, P. P., & Agrawal, A. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838014 · Cited by 212
Delivery of 125 I-NGF to the Brain via the Olfactory Route
Frey, W. H., Liu, J., Chen, X., Thorne, R. G., Fawcett, J. R., Ala, T. A., & Rahman, Y. (1997) · Drug Delivery · doi:10.3109/10717549709051878 · Cited by 210
Nanoparticulate Alternatives for Drug Delivery
Adair, J. H., Parette, M. R., Altınoğlu, E. İ., & KESTER, M. A. (2010) · ACS Nano · doi:10.1021/nn102324e · Cited by 208
Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration
Gao, X., Wu, B., Zhang, Q., Chen, J., Zhu, J., Zhang, W., Rong, Z., Chen, H., & Jiang, X. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.026 · Cited by 207
Morphology of olfactory epithelium in humans and other vertebrates
Morrison, E. E., & Costanzo, R. M. (1992) · Microscopy Research and Technique · doi:10.1002/jemt.1070230105 · Cited by 207
Nasal Drug Delivery in Humans
Bitter, C., Suter, K., & Surber, C. (2011) · Current problems in dermatology · doi:10.1159/000321044 · Cited by 203
Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease
Zhang, C., Chen, J., Feng, C., Shao, X., Liu, Q., Zhang, Q., Pang, Z., & Jiang, X. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.049 · Cited by 198
Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration
Gartziandia, O., Herrán, E., Pedraz, J. L., Carro, E., Igartúa, M., & Hernández, R. M. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.06.054 · Cited by 195
Trigeminal Pathways Deliver a Low Molecular Weight Drug from the Nose to the Brain and Orofacial Structures
Johnson, N. J., Hanson, L. R., & Frey, W. H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100029t · Cited by 194
Evidence of nose-to-brain delivery of nanoemulsions: Cargoes but not vehicles
Ahmad, E., Feng, Y., Qi, J., Fan, W., Ma, Y., He, H., Xia, F., Dong, X., Zhao, W., Lu, Y., et al. (2017) · Nanoscale · doi:10.1039/c6nr07581a · Cited by 194
Olfactory deposition of inhaled nanoparticles in humans
Garcia, G. J. M., Schroeter, J. D., & Kimbell, J. S. (2015) · Inhalation Toxicology · doi:10.3109/08958378.2015.1066904 · Cited by 191
Olfactory/trigeminal interactions in nasal chemoreception
Brand, G. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.01.002 · Cited by 190
Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery – A review for multidisciplinary researchers
Islam, N., & Cleary, M. J. (2012) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2011.12.025 · Cited by 188
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
Patel, S., Chavhan, S. S., Soni, H., Babbar, A. K., Mathur, R., Mishra, A. K., & Sawant, K. K. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.523787 · Cited by 187
Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium
Mistry, A., Stolnik, S., & Illum, L. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00088 · Cited by 185
Nose-to-brain peptide delivery – The potential of nanotechnology
Samaridou, E., & Alonso, M. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.001 · Cited by 183
Crowding in Cellular Environments at an Atomistic Level from Computer Simulations
Feig, M., Yu, I., Wang, P.-H., Nawrocki, G., & Sugita, Y. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b03570 · Cited by 182
Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting
Kumar, M., Misra, A., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802476504 · Cited by 179
Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery
Sharma, S., Lohan, S., & Murthy, R. S. R. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.789051 · Cited by 163
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
Woensel, M. V., Wauthoz, N., Rosière, R., Amighi, K., Mathieu, V., Lefranc, F., Gool, S. V., & Vleeschouwer, S. D. (2013) · Cancers · doi:10.3390/cancers5031020 · Cited by 162
Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation
Haque, S., Md, S., Fazil, M., Kumar, M., Sahni, J. K., Ali, J., & Baboota, S. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.02.051 · Cited by 161
Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems
Sharma, S., Mukkur, T. K. S., Benson, H. A., & Chen, Y. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21493 · Cited by 160
Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration
Xia, H., Gao, X., Gu, G., Liu, Z., Zeng, N., Hu, Q., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.004 · Cited by 152
Brain delivery of olanzapine by intranasal administration of transfersomal vesicles
Ha, S., Mahmoud, A. A. K., Kamel, A. O., Hady, M. A., & Awad, G. A. S. (2012) · Journal of Liposome Research · doi:10.3109/08982104.2012.700460 · Cited by 151
The Olfactory Neuron and the Blood-Brain Barrier
de Lorenzo, A. J. D. (2008) · Novartis Foundation symposium · doi:10.1002/9780470715369.ch9 · Cited by 150
Laminar Airflow and Nanoparticle or Vapor Deposition in a Human Nasal Cavity Model
Shi, H., Kleinstreuer, C., & Zhang, Z. (2006) · Journal of Biomechanical Engineering · doi:10.1115/1.2244574 · Cited by 149
Solid microparticles based on chitosan or methyl-β-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate
Rassu, G., Soddu, E., Cossu, M., Brundu, A., Cerri, G., Marchetti, N., Ferraro, L., Regan, R. F., Giunchedi, P., Gavini, E., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.025 · Cited by 148
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
Hoosain, F. G., Choonara, Y. E., Tomar, L. K., Kumar, P., Tyagi, C., du Toit, L. C., & Pillay, V. (2015) · BioMed Research International · doi:10.1155/2015/484963 · Cited by 146
Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach
Pavan, B., Dalpiaz, A., Ciliberti, N., Biondi, C., Manfredini, S., & Vertuani, S. (2008) · Molecules · doi:10.3390/molecules13051035 · Cited by 145
Recent advances in nanocarrier-based mucosal delivery of biomolecules
Kammona, O., & Kiparissides, C. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.040 · Cited by 142
Self-citation
Brain targeting of olanzapine via intranasal delivery of core–shell difunctional block copolymer mixed nanomicellar carriers: In vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies
Abdelbary, G. A., & Tadros, M. I. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.084 · Cited by 138
Mathematical modeling of molecular diffusion through mucus
Cu, Y., & Saltzman, W. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.006 · Cited by 134
Central projections of trigeminal primary afferents innervating the nasal mucosa: A horseradish peroxidase study in the rat
Anton, F., & Peppel, P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90354-q · Cited by 133
Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium
Mistry, A., Glud, S. Z., Kjems, J., Randel, J., Howard, K. A., Stolnik, S., & Illum, L. (2009) · Journal of drug targeting · doi:10.1080/10611860903055470 · Cited by 131
Unveiling the Molecular Structure of Pulmonary Surfactant Corona on Nanoparticles
Hu, Q., Bai, X., Hu, G., & Zuo, Y. Y. (2017) · ACS Nano · doi:10.1021/acsnano.7b01873 · Cited by 130
Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting
Jogani, V. V., Shah, P., Mishra, P., Mishra, A. K., & Misra, A. R. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318157205b · Cited by 127
Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans
Ruigrok, M. J. R., & de Lange, E. C. M. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9724-x · Cited by 126
Numerical simulation of aerosol deposition in a 3-D human nasal cavity using RANS, RANS/EIM, and LES
Liu, Y., Matida, E. A., Gu, J., & Johnson, M. R. (2007) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2007.05.003 · Cited by 123
Vaccine delivery carriers: Insights and future perspectives
Correia‐Pinto, J., Csaba, N., & Alonso, M. J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.047 · Cited by 122
Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain
Hanafy, A. S., Farid, R. M., & El-Gamal, S. S. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1062897 · Cited by 119
Uptake of exogenous proteins in mouse olfactory cells
Kristensson, K., & Olsson, Y. (1971) · Acta Neuropathologica · doi:10.1007/bf00688493 · Cited by 117
Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery
Lungare, S., Hallam, K., & Badhan, R. K. S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.042 · Cited by 117
Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses
Al-Ghananeem, A. M., Saeed, H. M., Florence, R. L., Yokel, R. A., & Malkawi, A. H. (2009) · Journal of drug targeting · doi:10.3109/10611860903483396 · Cited by 116
Airway mucus: its components and function
Lillehoj, E. P., & Kim, K. C. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976990 · Cited by 115
Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats
Zhao, Y., Li, X., Lu, C., Lin, M., Chen, L., Xiang, Q., Zhang, M., Jin, R., Jiang, X., Shen, X., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.10.009 · Cited by 114
Formulation and device design to increase nose to brain drug delivery
Warnken, Z. N., Smyth, H. D. C., Watts, A. B., Weitman, S., Kuhn, J. G., & Williams, R. O. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.05.003 · Cited by 114
Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route
Pathak, R., Prasad Dash, R., Misra, M., & Nivsarkar, M. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.02.002 · Cited by 113
Simulation of sprayed particle deposition in a human nasal cavity including a nasal spray device
Inthavong, K., Ge, Q., Se, C. M. K., Yang, W. W., & Tu, J. Y. (2010) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2010.11.008 · Cited by 113
Phospholipid based colloidal poloxamer–nanocubic vesicles for brain targeting via the nasal route
Ha, S., Mahmoud, A. A. K., Kamel, A. O., Hady, M. A., & Awad, G. A. S. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.05.010 · Cited by 113
Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats
Bshara, H., Osman, R., Mansour, S., & El-Shamy, A. E.-H. A. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.08.027 · Cited by 113
The macromolecular crowding effect – from in vitro into the cell
Gnutt, D., & Ebbinghaus, S. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0161 · Cited by 110
Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency
Boche, M., & Pokharkar, V. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-016-0552-9 · Cited by 109
Lipid-based drug delivery systems (LDDS): Recent advances and applications of lipids in drug delivery
Chime, S. A. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajppx2013.0004 · Cited by 105
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles
Gioia, S. D., Trapani, A., Mandracchia, D., Giglio, E. D., Cometa, S., Mangini, V., Arnesano, F., Belgiovine, G., Castellani, S., Pace, L., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.019 · Cited by 104
Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment
Quintana, D. S., Westlye, L. T., Rustan, Ø. G., Tesli, N., Poppy, C. L., Smevik, H., Tesli, M., Røine, M., Mahmoud, R. A., Smerud, K. T., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.93 · Cited by 103
Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145565 · Cited by 102
Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery
Kumar, M., Pandey, R. S., Patra, K. C., Jain, S. K., Soni, M. L., Dangi, J. S., & Madan, J. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.06.041 · Cited by 99
Solanum tuberosumlectin-conjugated PLGA nanoparticles for nose-to-brain delivery:in vivoandin vitroevaluations
Chen, J., Zhang, C., Liu, Q., Shao, X., Feng, C., Shen, Y., Zhang, Q., & Jiang, X. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.622396 · Cited by 97
Nanoparticle transport across in vitro olfactory cell monolayers
Gartziandia, O., Egusquiaguirre, S. P., Bianco, J. I., Pedraz, J. L., Igartúa, M., Hernández, R. M., Véronique Préat, A., & Beloqui, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.046 · Cited by 97
New strategies to improve the intranasal absorption of insulin
Duan, X., & Mao, S. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.011 · Cited by 96
UEA I-bearing nanoparticles for brain delivery following intranasal administration
Gao, X., Chen, J., Tao, W.-Q., ZHU, J., Zhang, Q., CHEN, H., & JIANG, X. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.039 · Cited by 95
Screening of cationic compounds as an absorption enhancer for nasal drug delivery
Natsume, H., Iwata, S., Ohtake, K., Miyamoto, M., Yamaguchi, M., Hosoya, K., Kobayashi, D., Sugibayashi, K., & Morimoto, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00100-3 · Cited by 93
Ciliated and microvillous structures of rat olfactory and nasal respiratory epithelia
Menco, B. P. M. (1984) · Cell and Tissue Research · doi:10.1007/bf00217846 · Cited by 93
Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: Implications in peptide delivery from nonoral routes
Yamamoto, A., Hayakawa, E., & Lee, V. H. L. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90492-a · Cited by 92
Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: Looking for the grail
Juillerat‐Jeanneret, L., & Schmitt, F. (2006) · Medicinal Research Reviews · doi:10.1002/med.20086 · Cited by 90
A quantitative analysis of isotope concentration profiles and rapid transport velocities in the C‐fibers of the garfish olfactory nerve
Gross, G. W., & Beidler, L. M. (1975) · Journal of Neurobiology · doi:10.1002/neu.480060208 · Cited by 89
Axonal Transport of Cadmium in the Olfactory Nerve of the Pike
Gottofrey, J., & Tjälve, H. (1991) · Pharmacology & Toxicology · doi:10.1111/bcpt.1991.69.4.242 · Cited by 86
Nose-to-Brain Transport Pathways of Wheat Germ Agglutinin Conjugated PEG-PLA Nanoparticles
Liu, Q., Shen, Y., Chen, J., Gao, X., Feng, C., Wang, L., Zhang, Q., & Jiang, X. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0641-0 · Cited by 84
A Computational Study of Odorant Transport and Deposition in the Canine Nasal Cavity: Implications for Olfaction
Lawson, M., Craven, B. A., Paterson, E. G., & Settles, G. S. (2012) · Chemical Senses · doi:10.1093/chemse/bjs039 · Cited by 82
Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor
Chen, H., Yang, G., Getachew, H., Acosta, C., Sánchez, C. S., & Konofagou, E. E. (2016) · Scientific Reports · doi:10.1038/srep28599 · Cited by 77
Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration
Ramsay, R. R., Májeková, M., Medina, M., & Valoti, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00375 · Cited by 76
Brain uptake of an anti-ischemic agent by nasal administration of microparticles
Dalpiaz, A., Gavini, E., Colombo, G., Russo, P., Bortolotti, F., Ferraro, L., Tanganelli, S., Scatturin, A., Menegatti, E., & Giunchedi, P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21335 · Cited by 75
Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs
Gonçalves, V. S. S., Matias, A. A., Poejo, J., Serra, T., & Duarte, C. M. M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.086 · Cited by 72
Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs
Oliveira, P., Fortuna, A. C., Alves, G., & Falcão, A. C. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160406120509 · Cited by 71
Production and characterization of novel chitosan nanoparticles for controlled release of rHu-Erythropoietin
Bulmer, C., Margaritis, A., & Xenocostas, A. (2012) · Biochemical Engineering Journal · doi:10.1016/j.bej.2012.07.007 · Cited by 68
Delivery of peptides to the brain: Emphasis on therapeutic development
Banks, W. A. (2008) · Biopolymers · doi:10.1002/bip.20980 · Cited by 68
Nasal-to-CNS Drug Delivery: Where are We Now and Where are We heading? an Industrial Perspective
Landis, M. S., Boyden, T. L., & Pegg, S. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.149 · Cited by 66
Systemic and Direct Nose-to-Brain Transport Pharmacokinetic Model for Remoxipride after Intravenous and Intranasal Administration
Stevens, J., Ploeger, B. A., van der Graaf, P. H., Danhof, M., & de Lange, E. C. M. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040782 · Cited by 64
A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles
Şekerdağ, E., Lüle, S., Pehlivan, S. B., Öztürk, N., Kara, A., Kaffashi, A., Vural, İ., Işıkay, İ., Yavuz, B., Oğuz, K. K., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.032 · Cited by 64
Improved nasal absorption of drugs using poly-l-arginine: effects of concentration and molecular weight of poly-l-arginine on the nasal absorption of fluorescein isothiocyanate–dextran in rats
Miyamoto, M., Natsume, H., Iwata, S., Ohtake, K., Yamaguchi, M., Kobayashi, D., Sugibayashi, K., Yamashina, M., & Morimoto, Y. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00149-7 · Cited by 63
Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat
Wang, Y., Aun, R. L., & Tse, F. L. S. (1998) · Biopharmaceutics & Drug Disposition · doi:10.1002/(sici)1099-081x(199812)19:9 · Cited by 62
Effects of proteolytic enzyme inhibitors on nasal absorption of salmon calcitonin in rats
Morimoto, K., Miyazaki, M., & Kakemi, M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00158-2 · Cited by 61
Reaching new levels of realism in modeling biological macromolecules in cellular environments
Feig, M., & Sugita, Y. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.08.017 · Cited by 61
Lipid-Based Nanocarriers for the Oral Administration of Biopharmaceutics
Karamanidou, T., Bourganis, V., Kammona, O., & Kiparissides, C. A. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0265 · Cited by 60
Self-citation
Enhancing CNS Repair in Neurological Disease
Xu, X., Warrington, A. E., Bieber, A. J., & Rodriguez, M. (2011) · CNS Drugs · doi:10.2165/11587830-000000000-00000 · Cited by 59
Mechanism of Nasal Absorption of Drugs II: Absorption of l-Tyrosine and the Effect of Structural Modification on its Absorption
Huang, C. H., Kimura, R., Bawarshi, R., & HUSSAIN, A. A. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600741210 · Cited by 58
Improved Transnasal Transport and Brain Uptake of Tizanidine HCl-Loaded Thiolated Chitosan Nanoparticles for Alleviation of Pain
Patel, D. H., Naik, S., & Misra, A. R. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22780 · Cited by 56
Mucoadhesive Amphiphilic Methacrylic Copolymer-Functionalized Poly(ε-caprolactone) Nanocapsules for Nose-to-Brain Delivery of Olanzapine
da Fonseca, F. N., Betti, A. H., Carvalho, F. C., Gremião, M. P. D., Dimer, F. A., Guterres, S. S., Tebaldi, M. L., Rates, S. M. K., & Pohlmann, A. R. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.2078 · Cited by 56
Influence of Chitosan Glutamate on the in vivo Intranasal Absorption of Rokitamycin from Microspheres
Gavini, E., Rassu, G., Ferraro, L., Generosi, A., Rau, J. V., Brunetti, A., Giunchedi, P., & Dalpiaz, A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22382 · Cited by 54
Effects of Proteolytic Enzyme Inhibitors on the Nasal Absorption of Vasopressin and an Analogue
Morimoto, K., Yamaguchi, H., Iwakura, Y., Miyazaki, M., Nakatani, E., Iwamoto, T., Ohashi, Y., & Nakai, Y. (1991) · Pharmaceutical Research · doi:10.1023/a:1015862603939 · Cited by 53
Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats
Wang, J., Sakai, S., Deguchi, Y., Bi, D., Tabata, Y., & Morimoto, K. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778367 · Cited by 53
Formulation of olfactory-targeted microparticles with tamarind seed polysaccharide to improve nose-to-brain transport of drugs
Yarragudi, S. B., Richter, R., Lee, H., Walker, G. F., Clarkson, A. N., Kumar, H., & Rizwan, S. B. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.01.044 · Cited by 50
Effects of Enzymatic Inhibition and Increased Paracellular Shunting on Transport of Vasopressin Analogues in the Rat
Ungell, A.-L. B., Andreasson, A., Lundin, K., & Utter, L. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810710 · Cited by 46
Intranasal Clobazam Delivery in the Treatment of Status Epilepticus
Florence, K., Lalan, M. S., Kumar, B. A., Ankur, K., Mishra, A. K., & Misra, A. R. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22307 · Cited by 45
Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development.
Wen, M. M. (2011) · PubMed · Cited by 44
Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling
Vulović, A., Geroski, T., Cvijić, S., Ibric, S. R., & Filipović, N. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.10.022 · Cited by 44
Human nasal olfactory deposition of inhaled nanoparticles at low to moderate breathing rate
Tian, L., Shang, Y., Dong, J., Inthavong, K., & Tu, J. Y. (2017) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2017.08.006 · Cited by 41
A morphometric comparison of the olfactory epithelium of newborn and weanling rabbits
Meisami, E., Louie, J. K., Hudson, R., & Distel, H. (1990) · Cell and Tissue Research · doi:10.1007/bf00327749 · Cited by 40
Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain
Ved, P. M., & Kim, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.040 · Cited by 40
Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief
Patel, D. H., Naik, S., Chuttani, K., Mathur, R., Mishra, A. K., & Misra, A. R. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.818676 · Cited by 37
Nanoscale carriers for targeted delivery of drugs and therapeutic biomolecules
Kiparissides, C. A., & Kammona, O. (2012) · The Canadian Journal of Chemical Engineering · doi:10.1002/cjce.21685 · Cited by 35
Self-citation
Lidocaine distribution into the CNS following nasal and arterial delivery: a comparison of local sampling and microdialysis techniques
Chou, K.-J., & Donovan, M. D. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00170-7 · Cited by 34
Intranasal Delivery of PEGylated Salmon Calcitonins: Hypocalcemic Effects in Rats
Lee, K. C., Myung Ok, P. A. R. K., Na, D. H., Youn, Y. S., Lee, S. D., Yoo, S. D., Lee, H. S., & DeLuca, P. P. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-0034-9 · Cited by 34
Nose-to-Brain delivery of insulin for Alzheimer’s disease
Stützle, M., Flamm, J., Carle, S., & Schindowski, K. (2015) · ADMET & DMPK · doi:10.5599/admet.3.3.184 · Cited by 34
Olfactory Absorption of Insulin to the Brain
Sigurdsson, P., Thorvaldsson, T., Gizurarson, S. S., & Gunnarsson, E. (1997) · Drug Delivery · doi:10.3109/10717549709051892 · Cited by 33
A Model for the Transient Subdiffusive Behavior of Particles in Mucus
Ernst, M., John, T., Guenther, M., Wagner, C., Schaefer, U. F., & Lehr, C. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2016.11.900 · Cited by 33
A quantitative study of anterograde and retrograde axonal transport of exogenous proteins in olfactory nerve C-fibers
Buchner, K., Seitz‐Tutter, D., Schönitzer, K., & Weiss, D. G. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90366-6 · Cited by 32
Intranasal Cabergoline: Pharmacokinetic and Pharmacodynamic Studies
Sharma, G., Mishra, A. K., Mishra, P., & Misra, A. R. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9329-8 · Cited by 32
Counter Current Transfer of Oxytocin from the Venous Blood of the Perihypophyseal Cavernous Sinus to the Arterial Blood of Carotid Rete Supplying the Hypophysis and Brain Depends on the Phase of the Estrous Cycle in Pigs1
Grzegorzewski, W. J., Skipor, J., Wasowska, B. A., & Krzymowski, T. (1995) · Biology of Reproduction · doi:10.1095/biolreprod52.1.139 · Cited by 32
Characterization of human nasal primary culture systems to investigate peptide metabolism
Hoang, V. D., Agu, R. U., Jorissen, M., Renaat, K., & Verbeke, N. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00077-7 · Cited by 31
Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles
Zhao, A., & Rodgers, V. G. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.018 · Cited by 30
A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug
Bagger, M. A., & Bechgaard, E. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.017 · Cited by 30
Local Transfer of Diazepam, but Not of Cocaine, from the Nasal Cavities to the Brain Arterial Blood in Rats
Einer‐Jensen, N., & Larsen, L. (2000) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2000.pto870606.x · Cited by 29
Aerosol-Stable Peptide-Coated Liposome Nanoparticles: A Proof-of-Concept Study with Opioid Fentanyl in Enhancing Analgesic Effects and Reducing Plasma Drug Exposure
Hoekman, J., Srivastava, P., & Ho, R. J. Y. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24022 · Cited by 28
Thermodynamics of Macromolecular Association in Heterogeneous Crowding Environments: Theoretical and Simulation Studies with a Simplified Model
Ando, T., Yu, I., Feig, M., & Sugita, Y. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b06243 · Cited by 28
Evaluation of the Internal Particle Morphology in Catalytic Gas-Phase Olefin Polymerization Reactors
Kanellopoulos, V., Tsiliopoulou, E., Dompazis, G., Touloupides, V., & Kiparissides, C. A. (2007) · Industrial & Engineering Chemistry Research · doi:10.1021/ie060721s · Cited by 27
Self-citation

Research works printed but not linked: 5

M. Dahlin, Nasal administration of compounds active in the Central Nervous System - Exploring the olfactory pathway, Uppsala University, Ph.D Dissertation, (2000).
V. Dhamankar, Cytochrome P450-mediated drug metabolizing activity in the nasal mucosa, The University of Iowa, Ph.D Dissertation, 2013.
Pardeshi, 2015, Novel nasal devices for the efficient drug delivery: A systemic review, Indian J. Nov. Drug Deliv., 7, 1
A. Mistry, The development and application of biological models for evaluation of direct nose-to-brain drug delivery systems. Ph.D Dissertation, University of Nottingham, (2009).
K. Inthavong, K. Zhang, J. Tu, Modelling submicron and micron particle deposition in a human nasal cavity, Seventh International Conference on CFD in the Minerals and Process Industries, CSIRO, Melbourne, Australia, 2009.

Sorted by citations

Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
Gänger, S., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030116 · Cited by 447
Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomes
Wu, I. Y., Bala, S., Škalko-Basnet, N., & di Cagno, M. P. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105026 · Cited by 439
Drug delivery to the central nervous system
Nance, E. A., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 442
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
Costa, C. P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 317

See all 357

Authors: Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C.
Affiliations: Aristotle University of Thessaloniki (GR)
Centre for Research and Technology Hellas (GR)
Corresponding author: Kiparissides, Costas
ORCID: Bourganis, Vassilis
Kammona, Olga
Alexopoulos, Aleck
Kiparissides, Costas
Venue: European Journal of Pharmaceutics and Biopharmaceutics
Publisher: Elsevier BV
Published: 2018-07
Volume: 128
Pages: 337-362
ISSN: 0939-6411 (ISSN-L)
DOI: 10.1016/j.ejpb.2018.05.009
OpenAlex: W2801808920
Cited by: 357
References: 219
Citations by year: 2026: 31 · 2025: 39 · 2024: 52 · 2023: 61 · 2022: 53 · 2021: 54 · 2020: 38 · 2019: 23 · 2018: 6
FWCI: 2.63
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: European Journal of Pharmaceutics and Biopharmaceutics (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: European Framework Programme for Research and Innovation Horizon 2020 (721098)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: nose-to-brain delivery, blood-brain barrier, brain drug delivery, central nervous system disorders, multiple sclerosis, Alzheimer's disease, intranasal drug delivery
MeSH terms: Administration, Intranasal, Animals, Biological Transport, Blood-Brain Barrier, Brain, Central Nervous System Agents, Central Nervous System Diseases, Drug Carriers, Epithelium, Humans, Nasal Mucosa, Permeability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks